Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Pneumococcal vaccine

¹Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney.

Australian Family Physician

|August 1, 1997

Summary

Pneumococcal infections pose significant risks, especially for adults with chronic illnesses. The 23-valent pneumococcal vaccine demonstrates effectiveness in specific high-risk groups, warranting wider use according to guidelines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Otitis media at 6-monthly assessments of Australian First Nations children between ages 12-36 months: Findings from two randomised controlled trials of combined pneumococcal conjugate vaccines.

International journal of pediatric otorhinolaryngology·2023

Same author

The expanding role of extracorporeal membrane oxygenation retrieval services in Australia.

Anaesthesia and intensive care·2017

Same author

Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2015

Same author

A case of portopulmonary hypertension spanning 18 years: successful use of bosentan for progressive disease after two liver transplantations.

Internal medicine journal·2012

Same author

International retrieval of adults on extracorporeal membrane oxygenation support.

Anaesthesia and intensive care·2011

Same author

Effectiveness of 7-valent pneumococcal conjugate vaccine against radiologically diagnosed pneumonia in indigenous infants in Australia.

Bulletin of the World Health Organization·2010

Area of Science:

Infectious Diseases
Immunology
Public Health

Background:

Pneumococcal infection presents a major global health challenge, increasing morbidity and mortality in adults, particularly those with chronic illnesses.
Current pneumococcal vaccines have limitations in efficacy for young children and severely immunocompromised individuals.

Purpose of the Study:

To evaluate the effectiveness of the 23-valent pneumococcal vaccine in specific adult populations.
To assess the safety and recommended usage of the pneumococcal vaccine.

Main Methods:

Review of case control and cohort studies.
Analysis of vaccine effectiveness in patients with chronic illnesses and post-splenectomy.

Main Results:

The 23-valent pneumococcal vaccine is effective in adults with specific chronic illnesses.
Effectiveness is also established in patients who have undergone splenectomy.
The vaccine is demonstrated to be safe for use in targeted populations.

Conclusions:

The 23-valent pneumococcal vaccine is a safe and effective tool for preventing pneumococcal disease in specific adult risk groups.
Wider adoption by healthcare practitioners for eligible patients, following current guidelines, is recommended to improve public health outcomes.

Related Experiment Videos